The benefits of genomic testing are primarily reported in rare disease, cancer diagnosis and
disease management. However, as research into its application in common, more complex …

The use of pharmacogenomic (PGx) tests is increasing, but there are not standard
approaches to counseling patients on their implications or results. To inform approaches for …

Examining community views on genetic/epigenetic research allows collaborative technology
development. Parent perspectives toward genetic/epigenetic testing for autism spectrum …

This study reports on the attitudes and perceptions toward pharmacogenomics (PGx) and
personalized medicine (PM) education among pharmacy and medical students in Malaysian …

Aim: To elicit preferences for pharmacogenomic (PGx) testing in polypharmacy patients.
Materials & methods: A face-to-face discrete choice experiment survey was designed and …

The increasing incorporation of genomics in clinical practice underscores the need to
improve genomics knowledge and familiarity among future health care providers. To this …

(1) Background: As genomic testing is becoming a part of the mainstream oncology practice,
it is vital to ensure that our patients fully understand the implications of these tests. This study …

International survey of patients undergoing percutaneous cor... : Pharmacogenetics and
Genomics International survey of patients undergoing percutaneous coronary intervention and …

This study aimed to explore the knowledge, factors affecting knowledge, and views of the
Jordanian population on genetics-related issues. A cross-sectional questionnaire study was …

Pancreatic cancer (PC) is the seventh most common cause of death with a poor prognosis.
Although there are many advanced therapeutic approaches, the 5-year survival rate of PC is …